We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CNTA market cap is 1.2B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2021 | Mar 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Revenue | 0 | 196k | 0 | 0 | 0 |
| Operating Income | -58.29M | -53.02M | -41.6M | -48.88M | -47.02M |
| Net Income | -60.77M | -54.5M | -43.17M | -50.71M | -24.89M |
| Year End December 30 2022 | 2021 | 2022 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -374.08M | -212.26M |
| Net Income | -381.07M | -216.21M |
| Quarter End | Dec 2021 | Mar 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Assets | 629.64M | 582.19M | 444.31M | 403.86M | 392.92M |
| Total Liabilities | 138.08M | 102.04M | 108.14M | 110.6M | 116.32M |
| Total Equity | 491.55M | 480.15M | 336.17M | 293.26M | 276.61M |
| Year End December 30 2022 | 2021 | 2022 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 629.64M | 444.31M |
| Total Liabilities | 138.08M | 108.14M |
| Total Equity | 491.55M | 336.17M |
| Quarter End | Dec 2021 | Mar 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Operating | -135.11M | -50.02M | -200.55M | -47.84M | -91.9M |
| Investing | 63.26M | -240k | -931k | -86.34M | -157.44M |
| Financing | 660.15M | 74k | 457k | N/A | 12k |
| Year End December 30 2022 | 2021 | 2022 |
|---|---|---|
| USD ($) | USD ($) | |
| Operating | -135.11M | -200.55M |
| Investing | 63.26M | -931k |
| Financing | 660.15M | 457k |
| Market Cap | 1.2B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 113.04M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.08 (17.88%) |
| Company Name | Centessa Pharmaceuticals PLC |
| Address |
3rd floor cheshire WA14 2DT |
| Website | https://www.centessa.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
